David M. Stern

Active 1988–2015

108
Papers
38,196
Citations
94
h-index
108
i10-index

Citations

Citations per year for David M. Stern1989: 2 citations1990: 1 citations1992: 4 citations1993: 3 citations1994: 1 citations1995: 5 citations1996: 18 citations1997: 83 citations1998: 96 citations1999: 178 citations2000: 247 citations2001: 340 citations2002: 390 citations2003: 506 citations2004: 654 citations2005: 695 citations2006: 661 citations2007: 679 citations2008: 723 citations2009: 740 citations2010: 750 citations2011: 675 citations2012: 622 citations2013: 514 citations2014: 451 citations2015: 402 citations2016: 354 citations2017: 355 citations2018: 345 citations2019: 839 citations2020: 932 citations2021: 815 citations2022: 611 citations2023: 463 citations2024: 555 citations2025: 271 citations2026: 2 citations1991: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,883 citing papers, 30.5% of this breakdownChina: 1,176 citing papers, 9.2% of this breakdownGermany: 788 citing papers, 6.2% of this breakdownJapan: 731 citing papers, 5.7% of this breakdownUnited Kingdom: 671 citing papers, 5.3% of this breakdownItaly: 622 citing papers, 4.9% of this breakdownCanada: 406 citing papers, 3.2% of this breakdownAustralia: 372 citing papers, 2.9% of this breakdownFrance: 324 citing papers, 2.6% of this breakdownIndia: 315 citing papers, 2.5% of this breakdownSouth Korea: 300 citing papers, 2.4% of this breakdownSpain: 245 citing papers, 1.9% of this breakdown
0%30.5%Other 22.7%

Fields

  • Biochemistry, Genetics and Molecular Biology42.7%
  • Medicine40.5%
  • Neuroscience8.2%
  • Immunology and Microbiology4.2%
  • Dentistry1.4%
  • Materials Science0.6%
  • Other2.4%

Topics

  • Advanced Glycation End Products research8.8%
  • Alzheimer's disease research and treatments7.3%
  • Neuroinflammation and Neurodegeneration Mechanisms3.3%
  • Mitochondrial Function and Pathology2.1%
  • S100 Proteins and Annexins2%
  • Immune Response and Inflammation1.7%
  • Other74.8%

Coauthors

All papers

Open in search
  1. RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2003 cited by 1,397

  2. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease

    Authors: , , , , , , , , , , , , , - Nature 1996 cited by 2,003

  3. ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease

    Authors: , , , , , , , , , , , , , , , , , , , , - Science 2004 cited by 1,292

  4. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE

    Authors: , , , , , - American Journal of Physiology-Endocrinology and Metabolism 2001 cited by 1,054

  5. Understanding RAGE, the receptor for advanced glycation end products

    Authors: , , , , , , , - Journal of Molecular Medicine 2005 cited by 1,275

  6. Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Brownlee, Peter W. Reeh, Peter P. Nawroth - Nature Medicine 2012 cited by 495

  7. RAGE‐dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease

    Authors: , , , , , , , , , , , , , , - The FASEB Journal 2009 cited by 325

  8. Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease

    Authors: , , , , , , , , , - The FASEB Journal 2005 cited by 734

  9. Endothelial cells in physiology and in the pathophysiology of vascular disorders.

    Authors: , , , , , , , , , , , , , , - 1998 cited by 2,261

  10. The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin

    Authors: , , , , , , , , , , , , - Journal of Biological Chemistry 1995 cited by 1,143

  11. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

    Authors: , , , - Journal of Clinical Investigation 2001 cited by 1,117

  12. Diabetes-Associated Sustained Activation of the Transcription Factor Nuclear Factor-κB

    Authors: , , , , , , , , , , , , , , , , , , , , , - Diabetes 2001 cited by 818

  13. Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases

    Authors: , , , , , , , , , , , , , , , , , , - Nature 2000 cited by 1,216

  14. RAGE Drives the Development of Glomerulosclerosis and Implicates Podocyte Activation in the Pathogenesis of Diabetic Nephropathy

    Authors: , , , , , , , , , , , , , , , , , - American Journal Of Pathology 2003 cited by 593

  15. Involvement of Microglial Receptor for Advanced Glycation Endproducts (RAGE) in Alzheimer's Disease: Identification of a Cellular Activation Mechanism

    Authors: , , , , , , , - Experimental Neurology 2001 cited by 437

  16. RAGE potentiates Aβ‐induced perturbation of neuronal function in transgenic mice

    Authors: , , , , , , , , , , , , , , , , , , , , , - The EMBO Journal 2004 cited by 327

  17. RAGE-mediated signaling contributes to intraneuronal transport of amyloid-β and neuronal dysfunction

    Authors: , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2009 cited by 293

  18. Transmission of cell stress from endoplasmic reticulum to mitochondria

    Authors: , , , , , , , , , , , , - The Journal of Cell Biology 2002 cited by 218

  19. β-Amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1

    Authors: , , , , , , , , - American Journal of Physiology-Cell Physiology 2000 cited by 216

  20. Blockade of Receptor for Advanced Glycation End-Products Restores Effective Wound Healing in Diabetic Mice

    Authors: , , , , , , , , , , , - American Journal Of Pathology 2001 cited by 428

  21. RAGE Blockade Stabilizes Established Atherosclerosis in Diabetic Apolipoprotein E–Null Mice

    Authors: , , , , , , , , , , , , - Circulation 2002 cited by 563

  22. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress

    Authors: , , , , , , , - Nature Medicine 2000 cited by 485

  23. Expression of Advanced Glycation End Products and Their Cellular Receptor RAGE in Diabetic Nephropathy and Nondiabetic Renal Disease

    Authors: , , , , , , , , - Journal of the American Society of Nephrology 2000 cited by 482

  24. RAGE and Alzheimer's Disease: A Progression Factor for Amyloid-β-Induced Cellular Perturbation?

    Authors: , , , - Journal of Alzheimer s Disease 2009 cited by 176